Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonistsYonghui Wang, Chaya Duraiswami, Kevin P Madauss, et al.
QJM : Monthly Journal of the Association of Physicians|August 22, 2012
Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patientsB D Bray, J Boyd, C Daly, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 27, 2013
How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipientsBenjamin D Bray, Jennifer Boyd, Conal Daly, et al.
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
British Journal of Cancer|August 10, 2007
Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survivalL Pitkin, S Luangdilok, C Corbishley, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonistsScott K Thompson, David G Washburn, James S Frazee, et al.
European Stroke Journal|April 23, 2019
Clinical risk scores for predicting stroke-associated pneumonia: A systematic reviewAmit K Kishore, Andy Vail, Benjamin D Bray, et al.
Breast Cancer Research and Treatment|September 8, 2019
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?T G Steenbruggen, N I Bouwer, C H Smorenburg, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
Pageof 22